Stock Market News1 month Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study? Investor's Business Daily
Vertex stock was floundering even before Thursday when the company’s non-opioid pain drug underperformed expectations in a midstage study.
The post Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study? appeared first on Investor's Busin…